S. No |
Age group in years |
Sex |
Total |
Male/female ratio |
|
Male
|
Female |
||||
1 |
0-15 |
2 |
3 |
5 |
1:15 |
2 |
16-30 |
27 |
6 |
33 |
1:0.22 |
3 |
31-45 |
13 |
5 |
18 |
1:0.38 |
4 |
46-60 |
8 |
7 |
15 |
1:0.87 |
5 |
Above 60 |
3 |
1 |
4 |
1:0.33 |
Total |
|
53 |
22 |
75 |
1:0.41 |
Trait
|
No of cases (%)
|
1. Laterality
Unilateral
Bilateral
|
71 (94.67%)
4(5.33%)
|
Socioeconomic
status
Lower
Middle
Upper
|
46(61.33)
27(36.0)
2 (2.67)
|
Habitat
Rural
Urban
|
36 (48.0%)
39(52.0%)
|
Etiology
Spontaneous
1. Vascular
disorder
i)
Perivasculitis
ii) Diabetes
mellitus
Iii)
Hypertension
2. Others
Trauma
|
53 (70.66)
36(48)
20(26.66)
13 (17.33)
3 (4)
17 (22.66)
22 (29.33)
|
S
No |
|
Duration
of Symptoms (weeks) |
Total |
|
|||
|
|
Less
than 1 |
1-4 |
5-8 |
More
than 8 |
No |
% |
1 |
Sudden loss of vision |
10 |
24 |
3 |
8 |
45 |
60.0% |
2 |
Red curtain in front of eye |
12 |
0 |
0 |
1 |
13 |
17.33% |
3 |
Blurring of vision ;sudden floater |
5 |
0 |
0 |
1 |
6 |
8.0% |
4 |
Gradual loss of vision |
1 |
2 |
0 |
2 |
5 |
6.67% |
5 |
No ocular complaint |
6 |
0 |
0 |
0 |
6 |
8.0% |
Total |
|
34 |
26 |
3 |
12 |
75 |
|
S. No |
Type of management |
No of patients |
Resolution |
Recurrence |
%of recurrence |
A |
Medical
m/m |
|
|
|
|
1 |
Anti
tubercular therapy |
20 |
5 |
13 |
65% |
2 |
Systemic
steroids |
20 |
8 |
9 |
45% |
3 |
Only
symptomatic t/t |
9 |
4 |
5 |
53.5% |
|
Total |
49 |
22 |
27 |
55% |
B |
Photocoagulation
|
10 |
9 |
1 |
10% |
Sr No |
Etiology |
Time taken for absorption(months) |
||||
1-2 |
2-4 |
4-5 |
More than 9 |
Not absorbed |
||
Spontaneous
|
|
|
|
|
|
|
1)vascular
disorder |
|
|
|
|
|
|
a)perivasculitis |
|
- |
7 |
7 |
4 |
1 |
b)Diabetes |
|
1 |
3 |
1 |
- |
3 |
c)hypertension |
|
1 |
2 |
- |
- |
- |
2)
others |
|
4 |
1 |
1 |
1 |
5 |
Ocular
trauma |
|
5 |
8 |
2 |
1 |
1 |
Total |
|
11 |
21 |
11 |
6 |
10 |
No |
Etiology |
On
Admision |
On
Follow Up |
||||||||||
|
|
*NO PL |
* HM |
*CF-2/60 |
3/60-6/60 |
6/36-6/18 |
6/12-6/6 |
NO PL |
HM |
CF-6/60 |
6/60-6/36 |
6/18-6/12 |
6/12-6/6 |
|
Spontaneous |
||||||||||||
1 |
Vascular Disorder |
1 |
10 |
16 |
7 |
- |
1 |
1 |
3 |
5 |
8 |
8 |
10 |
a) |
Perivacilitis |
- |
5 |
10 |
4 |
- |
1 |
- |
- |
3 |
3 |
7 |
7 |
b) |
*DM |
1 |
5 |
4 |
3 |
- |
- |
1 |
3 |
2 |
5 |
1 |
1 |
c) |
*HTN |
- |
- |
2 |
- |
- |
- |
- |
- |
- |
- |
- |
2 |
2 |
Others |
2 |
10 |
2 |
1 |
1 |
- |
3 |
7 |
2 |
- |
3 |
1 |
Ocular trauma |
4 |
10 |
6 |
1 |
- |
1 |
4 |
2 |
3 |
3 |
1 |
9 |
|
|
Total |
7 |
30 |
24 |
9 |
1 |
3 |
8 |
12 |
10 |
11 |
12 |
20 |
S
No |
Complication |
No
of cases |
% |
1 |
Fibrosis |
15 |
25.42% |
i)Retinal |
9 |
15.25% |
|
ii)vitreoretinal |
6 |
10.17% |
|
2 |
Neovascularization |
12 |
20.33% |
|
i)retinal |
4 |
6.78% |
|
ii)vitreoretinal |
6 |
10.17% |
|
Iii)iris |
2 |
3.38% |
3 |
Non absorption |
10 |
16.94% |
4 |
Fluid vitreous |
4 |
6.78% |
5 |
Retinal detachment |
3 |
5.08% |
6 |
Secondary glaucoma |
2 |
3.38% |
7 |
Macular degeneration |
2 |
3.38% |
8 |
Vitreous membrane |
2 |
3.38% |